Skip to content
Governance Register

← US public companies

Milestone Pharmaceuticals Inc.

SEC CIK 1408443 · MIST · last insider filing 2026-06-12

Directors (from insider filings)

NameCapacity as filedFilings
Papa Joseph C Director filed 2024 - 2026
Giles Lisa M. Director filed 2020 - 2026
Tomsicek Michael John Director filed 2019 - 2026
Fischer Seth H.Z. Director filed 2023 - 2026
Saik Andrew Director filed 2024 - 2026
Wills Robert James Director filed 2020 - 2026
Duty Stuart Director filed 2024 - 2026
Oliveto Joseph Director · President and CEO filed 2019 - 2026
Liebert Debra K. Director filed 2019 - 2025
Pasternak Richard C Director filed 2019 - 2023
Truex Paul F Director filed 2019 - 2022
Edick Paul R Director filed 2019 - 2020
Boorsma Marco Director filed 2019 - 2019
Kumar Nilesh Director filed 2019 - 2019

Officers (from insider filings)

NameTitle as filedFilings
Sandoval David I. GC & Chief Compliance Officer filed 2026 - 2026
Muller Lorenz Chief Commercial Officer filed 2019 - 2026
Hasija Amit CFO & EVP of Corp. Development filed 2019 - 2026
Bharucha David Chief Medical Officer filed 2022 - 2026
Nelson Jeffrey Edward Chief Operating Officer filed 2022 - 2026
Plat Francis Chief Medical Officer filed 2019 - 2021
Maness Timothy Vice President, Finance filed 2019 - 2019
Douville Philippe Chief Scientific Officer filed 2019 - 2019

About this record

From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.

Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.